1138 Investors following Plethico Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Buy Plethico Pharma, tgt Rs 569: Emkay
Emkay PCR has maintained buy rating on Plethico Pharma with target price of Rs 569. price of Rs 569. Post recommendation the scrip touched the peak of Rs 522. We believe that there is no change in the fundamentals of the company and the recent correction in the scrip has made its valuations further attractive.
Emkay PCR has maintained buy rating on Plethico Pharma with target price of Rs 569 in its June 16, 2008 report. "In the recent market corrections, Herbals and Nutraceuticals pharmaceutical major, Plethico Pharma Ltd fell by over 18% from our recommended price of Rs 436. We initiated coverage on the company with a BUY recommendation and a target price of Rs 569. Post recommendation the scrip touched the peak of Rs 522. We believe that there is no change in the fundamentals of the company and the recent correction in the scrip has made its valuations further attractive. We continue to maintain 'BUY' recommendation and previous target price of Rs 569" says Emkay report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
